Ogundiran Temidayo O, Ayandipo Omobolaji O, Ademola Adeyinka F, Adebamowo Clement A
Division of Oncology, Department of Surgery, College of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
BMC Surg. 2013 Dec 19;13:59. doi: 10.1186/1471-2482-13-59.
Modified radical mastectomy remains the standard therapeutic surgical operation for breast cancer in most parts of the world. This retrospective study reviews mastectomy for management of breast cancer in a surgical oncology division over a ten year period.
We reviewed the case records of consecutive breast cancer patients who underwent mastectomy at the Surgical Oncology Division, University College Hospital (UCH) Ibadan between November 1999 and October 2009.
Of the 1226 newly diagnosed breast cancer patients over the study period, 431 (35.2%) patients underwent mastectomy making an average of 43 mastectomies per year. Most patients were young women, premenopausal, had invasive ductal carcinoma and underwent modified radical mastectomy as the definitive surgical treatment. Prior to mastectomy, locally advanced tumors were down staged in about half of the patients that received neo-adjuvant combination chemotherapy. Surgical complication rate was low. The most frequent operative complication was seroma collection in six percent of patients. The average hospital stay was ten days and most patients were followed up at the surgical outpatients department for about two years post-surgery.
There was low rate of mastectomy in this cohort which could partly be attributable to late presentation of many patients with inoperable local or metastatic tumors necessitating only palliative or terminal care. Tumor down-staging with neo-adjuvant chemotherapy enhanced surgical loco-regional tumor control in some patients. The overall morbidity and the rates of postoperative events were minimal. Long-term post-operative out-patients follow-up was not achieved as many patients were lost to follow up after two years of mastectomy.
改良根治性乳房切除术在世界大部分地区仍是乳腺癌标准的治疗性外科手术。这项回顾性研究回顾了外科肿瘤学部门在十年期间对乳腺癌进行乳房切除术的情况。
我们回顾了1999年11月至2009年10月期间在伊巴丹大学学院医院(UCH)外科肿瘤学部门接受乳房切除术的连续性乳腺癌患者的病例记录。
在研究期间的1226例新诊断乳腺癌患者中,431例(35.2%)接受了乳房切除术,平均每年进行43例乳房切除术。大多数患者为年轻女性,处于绝经前,患有浸润性导管癌,并接受改良根治性乳房切除术作为确定性手术治疗。在乳房切除术之前,约一半接受新辅助联合化疗的患者中局部晚期肿瘤分期降低。手术并发症发生率较低。最常见的手术并发症是6%的患者出现血清肿。平均住院时间为10天,大多数患者在外科门诊接受术后约两年的随访。
该队列中乳房切除术的发生率较低,部分原因可能是许多患者因局部或转移性肿瘤无法手术而就诊较晚,仅需要姑息或终末期治疗。新辅助化疗使肿瘤分期降低,在一些患者中增强了手术对局部区域肿瘤的控制。总体发病率和术后事件发生率极低。由于许多患者在乳房切除术后两年失访,未实现长期术后门诊随访。